- Guide to PHARMACOLOGY
clindamycin is an approved drug (FDA (1970))
Compound class: Synthetic organic
Comment: Clindamycin is a semisynthetic lincosamide antibiotic with broad-spectrum activity. The compound also has antimalarial activity.
Clindamycin is one of the key access group antibacterials on the World Health Organisation's List of Essential Medicines (link provided in the Classification table above).
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
|Compound class||Synthetic organic|
|Ligand families/groups||Antimalarial ligands|
|Approved drug?||Yes (FDA (1970))|
|WHO Essential Medicine||WHO Model List of Essential Medicines (21st List, 2019). Access PDF version.|
|International Nonproprietary Names|
|CAS Registry No.||18323-44-9 (source: Scifinder)|
|GtoPdb PubChem SID||404859054|
|RCSB PDB Ligand||CLY|
|Search Google for chemical match using the InChIKey||KDLRVYVGXIQJDK-AWPVFWJPSA-N|
|Search Google for chemicals with the same backbone||KDLRVYVGXIQJDK|
|Search PubMed clinical trials||clindamycin|
|Search PubMed titles||clindamycin|
|Search PubMed titles/abstracts||clindamycin|
|Search UniChem for chemical match using the InChIKey||KDLRVYVGXIQJDK-AWPVFWJPSA-N|
|Search UniChem for chemicals with the same backbone||KDLRVYVGXIQJDK|